Effects of sibutramine treatment in obese adolescents: a randomized trial.

Childhood obesity. Lancet (2010) 5.47

Influence of race, ethnicity, and culture on childhood obesity: implications for prevention and treatment: a consensus statement of Shaping America's Health and the Obesity Society. Diabetes Care (2008) 1.74

Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study. Int J Obes (Lond) (2009) 1.60

Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial. Diabetes (2011) 1.32

Lifestyle and pharmacological approaches to weight loss: efficacy and safety. J Clin Endocrinol Metab (2008) 1.30

The genetics of human obesity. Ann N Y Acad Sci (2013) 1.22

Pediatric obesity: etiology and treatment. Endocrinol Metab Clin North Am (2009) 1.22

Weight-specific health-related quality of life in adolescents with extreme obesity. Obesity (Silver Spring) (2008) 1.19

Identifying patterns of eating and physical activity in children: a latent class analysis of obesity risk. Obesity (Silver Spring) (2010) 1.18

Weight loss reduces liver fat and improves hepatic and skeletal muscle insulin sensitivity in obese adolescents. Obesity (Silver Spring) (2009) 1.14

The use of sibutramine in the management of obesity and related disorders: an update. Vasc Health Risk Manag (2009) 1.09

Validation of a parent-proxy, obesity-specific quality-of-life measure: sizing them up. Obesity (Silver Spring) (2008) 1.06

Meal replacements in the treatment of adolescent obesity: a randomized controlled trial. Obesity (Silver Spring) (2010) 1.04

An evolving scientific basis for the prevention and treatment of pediatric obesity. Int J Obes (Lond) (2014) 1.00

Genetics of childhood obesity. J Obes (2011) 0.97

Safety and transparency of pediatric drug trials. Arch Pediatr Adolesc Med (2009) 0.95

Rise in antiobesity drug prescribing for children and adolescents in the UK: a population-based study. Br J Clin Pharmacol (2009) 0.95

Treatment of obesity in children and adolescents. J Pediatr Pharmacol Ther (2012) 0.93

Maintenance of weight loss in adolescents: current status and future directions. J Obes (2011) 0.93

Implications of gene-behavior interactions: prevention and intervention for obesity. Obesity (Silver Spring) (2008) 0.86

Pediatric obesity: parallels with addiction and treatment recommendations. Harv Rev Psychiatry (2008) 0.85

Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study. Obes Surg (2008) 0.84

IMPACT: a multi-level family and school intervention targeting obesity in urban youth. Contemp Clin Trials (2013) 0.83

Pharmacotherapy for childhood obesity: present and future prospects. Int J Obes (Lond) (2012) 0.83

Modeling transitions in body composition: the approach to steady state for anthropometric measures and physiological functions in the Minnesota human starvation study. Dyn Med (2008) 0.81

Pediatric obesity pharmacotherapy: current state of the field, review of the literature and clinical trial considerations. Int J Obes (Lond) (2016) 0.81

Pharmacological treatment of obesity in children and adolescents: present and future. J Obes (2010) 0.80

Impact of inclusion of industry trial results registries as an information source for systematic reviews. PLoS One (2014) 0.79

AMPK as Target for Intervention in Childhood and Adolescent Obesity. J Obes (2010) 0.79

The association between weight loss in caregivers and adolescents in a treatment trial of adolescents with obesity. J Pediatr Psychol (2013) 0.79

What constitutes successful weight management in adolescents? Ann Intern Med (2006) 0.78

Threshold for improvement in insulin sensitivity with adolescent weight loss. J Pediatr (2013) 0.78

Pediatric obesity: etiology and treatment. Pediatr Clin North Am (2011) 0.78

Tackling obesity: new therapeutic agents for assisted weight loss. Diabetes Metab Syndr Obes (2010) 0.76

Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy. Diabetes Metab Syndr Obes (2009) 0.76

Pediatric obesity: looking into treatment. Nutrients (2009) 0.75

Evaluation of a child for secondary causes of obesity and comorbidities. Nat Rev Endocrinol (2009) 0.75

How effective is sibutramine for the treatment of overweight adolescents? Nat Clin Pract Endocrinol Metab (2007) 0.75

Childhood obesity: a new menace. J Pediatr Pharmacol Ther (2007) 0.75

Adolescent bariatric surgery: "you may ask yourself: how did I get here?". J Pediatr Psychol (2013) 0.75

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74

Evidence based physical activity for school-age youth. J Pediatr (2005) 13.50

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med (2015) 11.05

AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation (2002) 9.04

Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med (2011) 7.16

Decline in physical activity in black girls and white girls during adolescence. N Engl J Med (2002) 7.06

Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation (2005) 7.04

Lipid screening and cardiovascular health in childhood. Pediatrics (2008) 6.62

Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension (2006) 5.59

Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med (2006) 5.18

Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics (2004) 5.01

Relation between the changes in physical activity and body-mass index during adolescence: a multicentre longitudinal study. Lancet (2005) 4.65

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med (2010) 4.52

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet (2010) 4.23

Guidelines for lipid screening in children and adolescents: bringing evidence to the debate. Pediatrics (2012) 3.98

A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab (2003) 3.93

Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation (2007) 3.90

Physical activity intervention studies: what we know and what we need to know: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity); Council on Cardiovascular Disease in the Young; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research. Circulation (2006) 3.72

Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation (2009) 3.59

Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation (2003) 3.33

Frequency of abnormal carbohydrate metabolism and diabetes in a population-based screening of adolescents. J Pediatr (2005) 3.23

Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension (2009) 3.22

Correlates of beverage intake in adolescent girls: the National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr (2006) 3.15

Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation (2006) 3.00

Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev (2006) 2.99

Cardiovascular health in childhood: A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation (2002) 2.96

Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association. Circulation (2012) 2.95

Racial differences in the relation between uncoupling protein genes and resting energy expenditure. Am J Clin Nutr (2002) 2.84

Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches: a scientific statement from the American Heart Association. Circulation (2013) 2.71

American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation (2003) 2.51

American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation (2003) 2.49

Parental report of outdoor playtime as a measure of physical activity in preschool-aged children. Arch Pediatr Adolesc Med (2004) 2.41

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol (2006) 2.41

Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium. Circulation (2010) 2.39

Effect of blinded peer review on abstract acceptance. JAMA (2006) 2.38

Dietary recommendations for children and adolescents: a guide for practitioners. Pediatrics (2006) 2.36

Twenty-four-hour ambulatory blood pressure in children with sleep-disordered breathing. Am J Respir Crit Care Med (2004) 2.34

Relationship between elevated arterial stiffness and increased left ventricular mass in adolescents and young adults. J Pediatr (2011) 2.34

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary. Crit Pathw Cardiol (2005) 2.31

Instability in the diagnosis of metabolic syndrome in adolescents. Circulation (2007) 2.29

Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation (2007) 2.26

Impact of objective and subjective social status on obesity in a biracial cohort of adolescents. Obes Res (2003) 2.24

Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr (2009) 2.21

Dietary recommendations for children and adolescents: a guide for practitioners: consensus statement from the American Heart Association. Circulation (2005) 2.16

Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth study. Diabetes Care (2006) 2.09

Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr (2004) 2.08

Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation (2011) 2.08

Childhood obesity predicts adult metabolic syndrome: the Fels Longitudinal Study. J Pediatr (2007) 2.07

Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study. J Pediatr (2006) 2.06

Roux-en-Y gastric bypass enhances energy expenditure and extends lifespan in diet-induced obese rats. Obesity (Silver Spring) (2009) 2.04

Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults. Cell Metab (2006) 2.02

Obesity development during adolescence in a biracial cohort: the NHLBI Growth and Health Study. Pediatrics (2002) 1.92

Systolic blood pressure in childhood predicts hypertension and metabolic syndrome later in life. Pediatrics (2007) 1.88

American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. J Pediatr (2003) 1.85

Childhood overweight and cardiovascular disease risk factors: the National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr (2007) 1.83

Nontraditional risk factors and biomarkers for cardiovascular disease: mechanistic, research, and clinical considerations for youth: a scientific statement from the American Heart Association. Circulation (2011) 1.81

Psychological adjustment of obese youth presenting for weight management treatment. Obes Res (2004) 1.78

Summary of the Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Hypertension (2004) 1.78

Dietary patterns associated with fat and bone mass in young children. Am J Clin Nutr (2010) 1.76

A randomized, placebo-controlled trial of amlodipine in children with hypertension. J Pediatr (2004) 1.75

Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children. Pediatr Infect Dis J (2003) 1.75

Influence of race, ethnicity, and culture on childhood obesity: implications for prevention and treatment: a consensus statement of Shaping America's Health and the Obesity Society. Diabetes Care (2008) 1.74

Dyslipidemia in youth with diabetes: to treat or not to treat? J Pediatr (2008) 1.72

Rational design of a combination medication for the treatment of obesity. Obesity (Silver Spring) (2008) 1.71

Best practice updates for pediatric/adolescent weight loss surgery. Obesity (Silver Spring) (2009) 1.71

Adiposity and TV viewing are related to less bone accrual in young children. J Pediatr (2008) 1.71

The relationship of health outcomes to improvement in BMI in children and adolescents. Obes Res (2005) 1.70

Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group. Circulation (2005) 1.67

American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers. Circulation (2013) 1.66

Prevalence of tobacco use and association between cardiometabolic risk factors and cigarette smoking in youth with type 1 or type 2 diabetes mellitus. J Pediatr (2010) 1.63

Baseline BMI is a strong predictor of nadir BMI after adolescent gastric bypass. J Pediatr (2010) 1.61

Increased arterial stiffness is found in adolescents with obesity or obesity-related type 2 diabetes mellitus. J Hypertens (2010) 1.60

Use of a DASH food group score to predict excess weight gain in adolescent girls in the National Growth and Health Study. Arch Pediatr Adolesc Med (2011) 1.60

Pubertal maturation in girls and the relationship to anthropometric changes: pathways through puberty. J Pediatr (2003) 1.59

Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol (2011) 1.58

Health-related quality of life and depressive symptoms in adolescents with extreme obesity presenting for bariatric surgery. Pediatrics (2006) 1.57

Youth with obesity and obesity-related type 2 diabetes mellitus demonstrate abnormalities in carotid structure and function. Circulation (2009) 1.56

Beriberi after gastric bypass surgery in adolescence. J Pediatr (2004) 1.56

Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension (2014) 1.55

The relationship of retinol binding protein 4 to changes in insulin resistance and cardiometabolic risk in overweight black adolescents. J Pediatr (2008) 1.54

Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents. Pediatrics (2009) 1.52

Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo. J Clin Endocrinol Metab (2009) 1.52

Factor analysis of clustered cardiovascular risks in adolescence: obesity is the predominant correlate of risk among youth. Circulation (2005) 1.51

Prevalence and incidence of hypertension in adolescent girls. J Pediatr (2010) 1.51

Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism. J Am Soc Nephrol (2005) 1.50

Evaluation of concentric left ventricular geometry in humans: evidence for age-related systematic underestimation. Hypertension (2004) 1.49

Serum lipids and glucose control: the SEARCH for Diabetes in Youth study. Arch Pediatr Adolesc Med (2007) 1.49

Breakfast consumption by African-American and white adolescent girls correlates positively with calcium and fiber intake and negatively with body mass index. J Am Diet Assoc (2005) 1.46

Cardiovascular effects of sibutramine in the treatment of obese adolescents: results of a randomized, double-blind, placebo-controlled study. Pediatrics (2007) 1.44

Prevalence of increased arterial stiffness in children with type 1 diabetes mellitus differs by measurement site and sex: the SEARCH for Diabetes in Youth Study. J Pediatr (2010) 1.43

Breastfeeding, introduction of complementary foods, and adiposity at 5 y of age. Am J Clin Nutr (2006) 1.40

Notice: the importance of adhering to The Journal's Guide for Authors. J Pediatr (2010) 1.39

Sleep in overweight adolescents: shorter sleep, poorer sleep quality, sleepiness, and sleep-disordered breathing. J Pediatr Psychol (2006) 1.38

Childhood obesity and cardiovascular disease: links and prevention strategies. Nat Rev Cardiol (2011) 1.38

Measures of arterial stiffness in youth with type 1 and type 2 diabetes: the SEARCH for diabetes in youth study. Diabetes Care (2010) 1.37

Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation (2003) 1.36

Primary prevention of cardiovascular disease in nursing practice: focus on children and youth: a scientific statement from the American Heart Association Committee on Atherosclerosis, Hypertension, and Obesity in Youth of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council on Nutrition, Physical Activity, and Metabolism. Circulation (2007) 1.34

Cardiac and vascular consequences of pre-hypertension in youth. J Clin Hypertens (Greenwich) (2011) 1.32

Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes. Diabetes Care (2013) 1.32